rs763721044

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5

The NM_022124.6(CDH23):​c.7903G>T​(p.Val2635Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

6
11
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:2

Conservation

PhyloP100: 9.96

Publications

5 publications found
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
CDH23 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_022124.6
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.946
PP5
Variant 10-71805836-G-T is Pathogenic according to our data. Variant chr10-71805836-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 228503.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.7903G>T p.Val2635Phe missense_variant Exon 56 of 70 ENST00000224721.12 NP_071407.4
CDH23NM_001171933.1 linkc.1183G>T p.Val395Phe missense_variant Exon 9 of 23 NP_001165404.1
CDH23NM_001171934.1 linkc.1183G>T p.Val395Phe missense_variant Exon 9 of 22 NP_001165405.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.7903G>T p.Val2635Phe missense_variant Exon 56 of 70 5 NM_022124.6 ENSP00000224721.9

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152204
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000282
AC:
7
AN:
248118
AF XY:
0.0000297
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000890
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000547
AC:
8
AN:
1461458
Hom.:
0
Cov.:
32
AF XY:
0.00000413
AC XY:
3
AN XY:
726986
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.000134
AC:
6
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86164
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111812
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152204
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41456
American (AMR)
AF:
0.000196
AC:
3
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000197
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal recessive nonsyndromic hearing loss 12;C1832845:Usher syndrome type 1D;C4539685:Pituitary adenoma 5, multiple types Pathogenic:1
Mar 26, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hearing loss, autosomal recessive Pathogenic:1
May 01, 2024
Laboratory of Human Genetics, Universidade de São Paulo
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

The CDH23:NM_022124.5:c.7903G>T variant has extremely low frequency in gnomAD population databases (PM2), reported in ClinVar in affected individuals (PP5), Cosegregation with disease in two affected family members in a gene definitively known to cause the disease (PP1), computational prediction tools unanimously support a deleterious effect on the gene (PP3). Here it was found in trans with c.3820G>A in two affected siblings, born from unaffected unrelated couple. -

Autosomal recessive nonsyndromic hearing loss 12 Pathogenic:1
Feb 19, 2016
Laboratory of Prof. Karen Avraham, Tel Aviv University
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

Congenital, profound HL -

not specified Uncertain:1
Dec 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Val2635Phe variant in CDH23 has been previously reported in 3 Jewish-Alger ian individuals with hearing loss (Brownstein 2011, Idan 2013). The variant was identified in the homozygous state in two of these individuals and was present i n the heterozygous state in the third individual who did not carry a second CDH2 3 variant on the other allele. The variant apparently segregated with the hearin g loss in affected family members in two pedigrees; however one family was consa nguineous (which increases the presence of homozygous variants in offspring irre spective of their clinical significance) and, although consanguinity was not rep orted for the second family, all affected family members, including two affected apparently unrelated spouses, were homozygous for the variant. The variant was not identified in 106 ethnically-matched controls; however, this sample size is too small to accurately determine the population frequency of the variant. Given that the variant has only been seen in the homozygous state and was not observe d in compound heterozygosity with a known CDH23 pathogenic variant in affected i ndividuals, as well as the fact that these families all have a unique shared anc estry with limited control data, the information in these studies does not provi de sufficient evidence to assume that the p.Val2635Phe variant is causative for hearing loss. The p.Val2635Phe variant has also been identified in 4/10962 of La tino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadins titute.org), but this frequency is not high enough to rule out a pathogenic role . Computational prediction tools and conservation analysis suggest that this var iant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, due to insufficient data to support pathog enicity, and the limited evidence and control data presented in the studies abov e, the clinical significance of the p.Val2635Phe variant in CDH23 is uncertain. -

not provided Uncertain:1
May 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 2635 of the CDH23 protein (p.Val2635Phe). This variant is present in population databases (rs763721044, gnomAD 0.01%). This missense change has been observed in individual(s) with deafness (PMID: 19888295, 21917145). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 228503). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.23
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.083
T;T;.;.
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.97
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.94
D;D;D;D
M_CAP
Uncertain
0.12
D
MetaRNN
Pathogenic
0.95
D;D;D;D
MetaSVM
Uncertain
-0.12
T
MutationAssessor
Uncertain
2.6
.;M;.;.
PhyloP100
10
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-3.0
.;D;.;D
REVEL
Uncertain
0.59
Sift
Uncertain
0.0010
.;D;.;D
Sift4G
Uncertain
0.0020
D;.;D;D
Polyphen
1.0
.;D;.;.
Vest4
0.94
MutPred
0.86
Loss of sheet (P = 0.0315);Loss of sheet (P = 0.0315);.;.;
MVP
0.90
MPC
0.72
ClinPred
0.98
D
GERP RS
5.9
Varity_R
0.67
gMVP
0.88
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs763721044; hg19: chr10-73565593; API